{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:42:41Z","timestamp":1790613761309,"version":"4.1.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Human papillomavirus (HPV) vaccination prevents several cancers and genital warts, yet adult uptake in Switzerland remains poorly characterized. In addition to demographic factors, understanding how individuals\u2019 knowledge, attitudes, and behaviors (KAB) are associated with vaccine uptake may support strategies to address coverage gaps.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate adult HPV vaccination uptake in Switzerland and evaluate how population-level KAB profiles are associated with vaccination uptake.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This nationwide, cross-sectional, population-based survey of adults throughout Switzerland was conducted between September 2023 and September 2024. Adults aged 18 to 45 years were randomly selected from a national residential registry using disproportionate stratified sampling by age, gender, and region. Participants completed a questionnaire on HPV-related KAB, and corresponding HPV immunization data were verified from individuals\u2019 personal vaccination records.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Individual KAB responses regarding HPV disease and vaccination, assessed through standardized questionnaires.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was documented receipt of 1 or more HPV vaccine dose according to vaccination records. Latent class analysis was used to define KAB profiles, and multivariable logistic regression used to assess associations with HPV vaccination.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 41\u202f645 valid addresses, 3847 individuals (9.2%) submitted both a questionnaire and a vaccination record and were included in the analysis. Among 3847 participants (2433 women [weighted 49.1%]; 1997 individuals aged 18-26 years [weighted 26.1%]), 27.2% (95% CI, 25.9%-28.6%) had received 1 or more HPV vaccine dose, with uptake varying by age (58.6% [95% CI, 56.2%-60.9%] for those aged 18-26 years vs 16.1% [95% CI, 14.6%-17.8%] for those aged 27-45 years), gender (42.8% [95% CI, 40.6%-45.0%] of women vs 12.2% [95% CI, 10.8%-13.8%] of men), and region. Three KAB profiles were identified: cluster 1 (2280 participants [52.9%]) showed high HPV awareness and perceived importance, cluster 2 (1099 participants [30.9%]) showed moderate knowledge and low perceived risk, and cluster 3 (468 participants [16.2%]) showed high uncertainty. Vaccination uptake was 41.1% (95% CI, 40.9%-41.2%) in cluster 1, 13.6% (95% CI, 13.4%-13.7%) in cluster 2, and 8.1% (95% CI, 7.9%-8.2%) in cluster 3. Lack of practitioner recommendation was the most common barrier to vaccination across profiles.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of Swiss adults, in addition to demographic factors, distinct KAB profiles were associated with HPV vaccine uptake. Tailored communication strategies that (1) reinforce practitioner engagement, (2) address risk perception and skepticism, and (3) improve informational outreach may help to address remaining coverage gaps.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.2780","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:30:21Z","timestamp":1774279821000},"page":"e262780","source":"Crossref","is-referenced-by-count":3,"title":["Knowledge, Attitudes, and Behaviors Toward Human Papillomavirus Vaccination Among Adults in Switzerland"],"prefix":"10.1001","volume":"9","author":[{"given":"Kyra","family":"Zens","sequence":"first","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Immunity and Vaccines Research Group, University of Zurich, Zurich, Switzerland"},{"name":"Institute for Experimental Immunology, Viral Immunobiology Research Group, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Baer","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Immunity and Vaccines Research Group, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Nur","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme AG, Lucerne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Renner","sequence":"additional","affiliation":[{"name":"Merck Sharp & Dohme AG, Lucerne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phung","family":"Lang","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Immunity and Vaccines Research Group, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"zoi260120r1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13027-017-0129-6","article-title":"Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe.","volume":"12","author":"Hartwig","year":"2017","journal-title":"Infect Agent Cancer"},{"key":"zoi260120r2","first-page":"10","article-title":"Three years of HPV vaccination programs in Switzerland: data synthesis 2007-2010.","volume":"5","author":"Masserey","year":"2010","journal-title":"Gyn\u00e4kologie"},{"issue":"1","key":"zoi260120r7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054419","article-title":"HPV vaccine awareness, knowledge and information sources among youth in Switzerland: a mixed methods study.","volume":"12","author":"Schwendener","year":"2022","journal-title":"BMJ Open"},{"issue":"5","key":"zoi260120r8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-021006","article-title":"Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.","volume":"8","author":"Riesen","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"zoi260120r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170550","article-title":"Barriers of influenza vaccination intention and behavior: a systematic review of influenza vaccine hesitancy, 2005-2016.","volume":"12","author":"Schmid","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"zoi260120r11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013430.pub2","article-title":"Factors that influence caregivers\u2019 and adolescents\u2019 views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis.","volume":"4","author":"Cooper","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"45","key":"zoi260120r12","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1016\/j.vaccine.2017.09.046","article-title":"A systematic review of factors affecting vaccine uptake in young children.","volume":"35","author":"Smith","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"zoi260120r13","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.4161\/hv.24657","article-title":"Vaccine hesitancy: an overview.","volume":"9","author":"Dub\u00e9","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"44","key":"zoi260120r14","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1016\/j.vaccine.2022.09.038","article-title":"Influence of cantonal health policy frameworks & activities on influenza vaccination rate in patients with non-communicable diseases in Switzerland.","volume":"40","author":"Ruckstuhl","year":"2022","journal-title":"Vaccine"},{"issue":"19","key":"zoi260120r15","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.","volume":"32","author":"Larson","year":"2014","journal-title":"Vaccine"},{"key":"zoi260120r16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.puhe.2022.02.002","article-title":"Public attitudes and influencing factors toward COVID-19 vaccination for adolescents\/children: a scoping review.","volume":"205","author":"Liu","year":"2022","journal-title":"Public Health"},{"issue":"6","key":"zoi260120r17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.vaccine.2021.12.059","article-title":"Factors associated with COVID-19 vaccination intentions among adults in the deep South.","volume":"40","author":"Daniel","year":"2022","journal-title":"Vaccine"},{"issue":"8","key":"zoi260120r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180759","article-title":"The impact of access to immunization information on vaccine acceptance in three countries.","volume":"12","author":"Handy","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"zoi260120r19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/vaccines8030500","article-title":"A consent support resource with benefits and harms of vaccination does not increase hesitancy in parents: an acceptability study.","volume":"8","author":"McDonald","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"zoi260120r20","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.759602","article-title":"Pneumococcal vaccination coverage and uptake among adults in Switzerland: a nationwide cross-sectional study of vaccination records.","volume":"9","author":"Zens","year":"2022","journal-title":"Front Public Health"},{"issue":"SI","key":"zoi260120r21","doi-asserted-by":"publisher","first-page":"SI68","DOI":"10.1093\/rheumatology\/keab432","article-title":"Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases.","volume":"60","author":"Felten","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"15","key":"zoi260120r22","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/healthcare12151458","article-title":"Comprehensive clustering analysis and profiling of COVID-19 vaccine hesitancy and related factors across U.S. counties: insights for future pandemic responses.","volume":"12","author":"Maleki","year":"2024","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"zoi260120r23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5993\/AJHB.44.3.3","article-title":"Cluster analysis: vaccination attitudes and beliefs of healthcare personnel.","volume":"44","author":"Bardenheier","year":"2020","journal-title":"Am J Health Behav"},{"issue":"10","key":"zoi260120r24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010437","article-title":"Spatial clustering in vaccination hesitancy: the role of social influence and social selection.","volume":"18","author":"Alvarez-Zuzek","year":"2022","journal-title":"PLoS Comput Biol"},{"issue":"49","key":"zoi260120r25","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1016\/j.vaccine.2020.10.022","article-title":"Analysis of tick-borne encephalitis vaccination coverage and compliance in adults in Switzerland, 2018.","volume":"38","author":"Baroutsou","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"zoi260120r26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247216","article-title":"A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland.","volume":"16","author":"Zens","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"zoi260120r28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208601","article-title":"Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination.","volume":"13","author":"Betsch","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"zoi260120r29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308159","article-title":"COVID-19 and influenza vaccine-hesitancy subgroups.","volume":"19","author":"M\u00e4ki","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"zoi260120r30","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12889-023-15334-2","article-title":"Vaccine hesitancy about the HPV vaccine among French young women and their parents: a telephone survey.","volume":"23","author":"Gauna","year":"2023","journal-title":"BMC Public Health"},{"key":"zoi260120r31","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2023.1605832","article-title":"Peri-pandemic acceptance of influenza and COVID-19 vaccination by Swiss healthcare workers in primary care 2020\/21: a cross-sectional study.","volume":"68","author":"Morgel","year":"2023","journal-title":"Int J Public Health"},{"issue":"2","key":"zoi260120r32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246970","article-title":"Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US.","volume":"16","author":"Latkin","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"zoi260120r33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1542\/peds.2007-0538","article-title":"Parents with doubts about vaccines: which vaccines and reasons why.","volume":"122","author":"Gust","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"zoi260120r34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00038-017-1050-x","article-title":"Human papillomavirus vaccine uptake in adolescence and adherence to cervical cancer screening in Switzerland: a national cross-sectional survey.","volume":"63","author":"Wymann","year":"2018","journal-title":"Int J Public Health"},{"key":"zoi260120r9","volume-title":"Cantonal School-Based Immunization Programs: Practices, Challenges, and Proposed Measures","author":"Lang","year":"2024"},{"key":"zoi260120r3","unstructured":"Federal Office of Public Health. The HPV vaccine is effective and safe. January 2018. Accessed February 13, 2026. https:\/\/www.bag.admin.ch\/dam\/de\/sd-web\/2jjLZJaza0vB\/hpv-impfung-wirksam-sicher.pdf"},{"key":"zoi260120r4","unstructured":"Federal Office of Public Health. Swiss immunization plan. 2024. Accessed February 5, 2024. https:\/\/www.bag.admin.ch\/de\/schweizerischer-impfplan"},{"key":"zoi260120r5","unstructured":"Compendium. Gardasil-9. Accessed February 5, 2024. https:\/\/compendium.ch\/product\/1327722-gardasil-9-inj-susp-fertspr\/mpro"},{"key":"zoi260120r6","unstructured":"Federal Office of Public Health. Cantonal vaccination coverage monitoring Switzerland. Published 2020. Accessed December 2020. https:\/\/www.bag.admin.ch\/de\/kantonales-durchimpfungsmonitoring-schweiz"},{"key":"zoi260120r27","unstructured":"Swiss Federal Statistical Office. Provisional demographic balance of the permanent resident population 2024 by canton, citizenship (category), sex, and age. March 4, 2025. Accessed February 13, 2026. https:\/\/www.bfs.admin.ch\/bfs\/en\/home.assetdetail.34267786.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846838\/zens_2026_oi_260120_1773672732.08931.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:30:23Z","timestamp":1774279823000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.2780","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}